October 2021, Poland – Comarch has been listed in the 2021 Gartner “Market Guide for CSP Revenue Management and Monetization Solutions”.
The “Market Guide for CSP Revenue Management and Monetization Solutions” report includes market definition, description, key findings and recommendations. According to this report:
“CIOs at CSPs who are modernizing or transforming their BSS or revenue management can use this research to hone sourcing strategies targeting desired outcomes”. “Gartner defines the revenue management and monetization solutions as commercial off-the-shelf software solutions that address communications service providers’ back-end operations requirements of rating, charging, billing, payments, collections, partner settlement, monetization and related activities.”*
Comarch has been listed among 14 Representative Vendors in the CSP RM&M solutions market.
“We believe that Comarch’s inclusion in the report, as a Representative Vendor, is a result of our strengthening position within the BSS area. Our continuous development of the business support systems allows our customers to fully utilize the potential behind monetizing new technologies, including much-desired 5G monetization” – says Anna Kozłowska-Jarosz, BSS Product Manager at Comarch.
The full report is available for Gartner subscribers here.
* Gartner, “Market Guide for CSP Revenue Management and Monetization Solutions”, Amresh Nandan, Chris Meering, Jouni Forsman, 12 October 2021
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the United States and internationally, and is used herein with permission. All rights reserved.
Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner® research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner® disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.